ChiCTR2000039133
结束
/
/
/
2020-10-18
/
/
精神分裂症
Randomized controlled trial of Enhancing Contact Model on reducing stigma of mental illness in family caregivers of persons with schizophrenia in rural China
Randomized controlled trial of Enhancing Contact Model on reducing stigma of mental illness in family caregivers of persons with schizophrenia in rural China
The study tests the short (post- intervention) and long-term (9-month follow-up) effectiveness of a newly developed Enhancing Contact Model (ECM) Intervention for reducing self-stigma in family caregivers of persons with schizophrenia, and examines whether ECM is more effective on reducing self-stigma than Psychoeducational Family Intervention (PFI).
随机平行对照
其它
Computer generated numbers for randomization
Not stated
Research Grants Council, University Grants Committee, General Research Fund
/
84;88;97
/
2018-09-01
2021-02-28
/
The inclusion criteria for family caregivers: 1. Being the father or mother of a person with schizophrenia identified in 2015; 2. Aged 38- 75 years; 3. Living together with and caring for the patient; 4. Not participants in our prior PFI studies; 5. Be able to provide written informed consent. The inclusion criteria for person with schizophrenia: 1. Be identified in the 2015 survey; 2. Aged >=18 years; 3. Not participants in our prior PFI studies.；
请登录查看The exclusion criteria for the family caregivers: 1. likely to engage in a risk behavior (e.g., suicide or violence) imminently; 2. Be identified by a trained health professional as unsuitable to join the study (e.g., with mental illness).；
请登录查看香港大學社會科學學院
/
标新生物GLUETACS2025-12-12
兽药资讯2025-12-12
医麦创新药2025-12-12
求实药社2025-12-12
卫材中国2025-12-12
药时空2025-12-12
Being科学2025-12-12
康华股份2025-12-12
康臣药业2025-12-12
汉康生技2025-12-12
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
